Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
RYSE Asset Management, founded in 2017, is a London-based venture capital firm. The firm focuses on HealthTech solutions, aiming to improve access, quality, and delivery of healthcare, especially in underserved areas. RYSE manages a portfolio of nine companies.
RYSE specializes in early-stage investments in HealthTech, primarily at the Seed and Series A stages. The firm targets sectors such as digital diagnostics, digital therapeutics, medical devices, and data and discovery platforms. Their investment thesis centers on addressing unmet clinical needs and making healthcare more affordable.
Notable portfolio companies include Braingaze, which develops eye-tracking technology for early detection of mental health disorders; Curio, focused on digital therapeutics for postpartum depression; and Skin Analytics, specializing in AI-driven cancer screening. Other companies include Ten63 Therapeutics, Second Nature, Knokcare, Log My Care, MediShout, and Oto.
Email your deck to investments@ryseam.com for consideration.
RYSE often leads investment rounds, particularly in Seed and Series A stages, to help shape the direction of their portfolio companies.
RYSE is open to follow-on investments, especially if the company continues to meet their investment thesis and demonstrates growth potential.
Specific details about the size of RYSE's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.